Insider · CIK 0001514980

Mueller Brian

CIK 0001514980 Name as filed on the most recent filing

Filed as Mueller Brian (33)

46 transaction lines · from 33 filings · filed 2012-02-14 to 2024-05-31 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

46 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2024-05-30 S, Open-market sale Biomarin Pharmaceutical IncBMRN 375,950, disposed Open Form 4 filing 0001048477-24-000114
2023-01-13 S, Open-market sale Biomarin Pharmaceutical IncBMRN 286,250, disposed Open Form 4 filing 0001567619-23-000965
2022-12-13 S, Open-market sale Biomarin Pharmaceutical IncBMRN 268,750, disposed Open Form 4 filing 0001567619-22-021667
2022-12-02 S, Open-market sale Biomarin Pharmaceutical IncBMRN 3 lines 731,605, disposed Open Form 4 filing 0001567619-22-021363
2022-11-23 S, Open-market sale Biomarin Pharmaceutical IncBMRN 3 lines 531,092, disposed Open Form 4 filing 0001567619-22-020937
2022-08-05 S, Open-market sale Biomarin Pharmaceutical IncBMRN 330,750, disposed Open Form 4 filing 0001567619-22-015384
2022-07-08 S, Open-market sale Biomarin Pharmaceutical IncBMRN 656,662, disposed Open Form 4 filing 0001567619-22-013907
2022-05-04 S, Open-market sale Biomarin Pharmaceutical IncBMRN 2 lines 997,100, disposed Open Form 4 filing 0001567619-22-009717
2021-05-07 S, Open-market sale Biomarin Pharmaceutical IncBMRN 533,366, disposed Open Form 4 filing 0001567619-21-009606
2021-04-01 S, Open-market sale Biomarin Pharmaceutical IncBMRN 434,300, disposed Open Form 4 filing 0001567619-21-007548
2019-04-05 S, Open-market sale Biomarin Pharmaceutical IncBMRN 277,582, disposed Open Form 4 filing 0001567619-19-008642
2018-08-07 S, Open-market sale Biomarin Pharmaceutical IncBMRN 261,250, disposed Open Form 4 filing 0001567619-18-000239
2018-06-22 S, Open-market sale Biomarin Pharmaceutical IncBMRN 2 lines 312,928, disposed Open Form 4 filing 0001140361-18-030005
2018-06-15 S, Open-market sale Biomarin Pharmaceutical IncBMRN 190,985, disposed Open Form 4 filing 0001140361-18-029042
2018-05-10 S, Open-market sale Biomarin Pharmaceutical IncBMRN 219,275, disposed Open Form 4 filing 0001140361-18-023458
2017-06-22 S, Open-market sale Biomarin Pharmaceutical IncBMRN 267,100, disposed Open Form 4 filing 0001140361-17-026024
2017-05-08 S, Open-market sale Biomarin Pharmaceutical IncBMRN 2 lines 687,334, disposed Open Form 4 filing 0001140361-17-019306
2016-08-01 S, Open-market sale Biomarin Pharmaceutical IncBMRN 28,700, disposed Open Form 4 filing 0001140361-16-074507
2015-03-03 S, Open-market sale Biomarin Pharmaceutical IncBMRN 766,210, disposed Open Form 4 filing 0001140361-15-010553
2014-12-02 S, Open-market sale Biomarin Pharmaceutical IncBMRN 459,100, disposed Open Form 4 filing 0001140361-14-044048
2014-12-01 S, Open-market sale Biomarin Pharmaceutical IncBMRN 627,238, disposed Open Form 4 filing 0001140361-14-044048
2014-11-26 S, Open-market sale Biomarin Pharmaceutical IncBMRN 302,508, disposed Open Form 4 filing 0001140361-14-043929
2013-05-14 S, Open-market sale Biomarin Pharmaceutical IncBMRN 2 lines 348,045, disposed Open Form 4 filing 0001140361-13-020906
2013-05-03 S, Open-market sale Biomarin Pharmaceutical IncBMRN 503,295, disposed Open Form 4 filing 0001140361-13-019035
2013-05-02 S, Open-market sale Biomarin Pharmaceutical IncBMRN 2 lines 610,354, disposed Open Form 4 filing 0001140361-13-019035
2013-03-01 S, Open-market sale Biomarin Pharmaceutical IncBMRN 300,067, disposed Open Form 4 filing 0001140361-13-010494
2013-03-01 S, Open-market sale Biomarin Pharmaceutical IncBMRN 120,510, acquired Open Form 4 filing 0001140361-13-010494
2012-11-15 S, Open-market sale Biomarin Pharmaceutical IncBMRN 790,600, disposed Open Form 4 filing 0001140361-12-048038
2012-11-05 S, Open-market sale Biomarin Pharmaceutical IncBMRN 2 lines 376,250, disposed Open Form 4 filing 0001140361-12-046031
2012-10-31 P, Open-market purchase Biomarin Pharmaceutical IncBMRN 11,924, acquired Open Form 4 filing 0001140361-13-006978
2012-07-10 S, Open-market sale Biomarin Pharmaceutical IncBMRN 106,250, disposed Open Form 4 filing 0001140361-12-032909
2012-07-02 S, Open-market sale Biomarin Pharmaceutical IncBMRN 110,800, disposed Open Form 4 filing 0001140361-12-032452
2012-05-08 S, Open-market sale Biomarin Pharmaceutical IncBMRN 589,050, disposed Open Form 4 filing 0001140361-12-024700
2012-05-08 S, Open-market sale Biomarin Pharmaceutical IncBMRN 589,050, disposed Open Form 4 filing 0001140361-12-024276
2012-02-24 S, Open-market sale Biomarin Pharmaceutical IncBMRN 175,325, disposed Open Form 4 filing 0001140361-12-011406
2011-10-31 P, Open-market purchase Biomarin Pharmaceutical IncBMRN 12,750, acquired Open Form 4 filing 0001140361-12-008335

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Codes on this page
S, Open-market sale
Open-market sale
P, Open-market purchase
Open-market purchase
Relationships on this page
O, Officer
Officer

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens. A row marked n lines adds up that many filed lines of one filing, on one day, on one side of the market; a filing whose lines fall across two pages is left as its lines on both, so no total here is ever short.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 2
  • Open-market sale 44
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. Mueller Brian, insider transactions. Retrieved 2026-08-23 from https://ebomi.com/insider/0001514980

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.